Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

LEO logo

LEO Pharma buys dermatology portfolio from Astellas

November 12, 2015 Sales and Marketing Astellas, LEO Pharma, acquisitions, dermatology, mergers

LEO Pharma, the speciality dermatology firm, is looking to expand its presence in the therapy area by buying Astellas’ portfolio …
News

Astellas to acquire Ocata Therapeutics in $379m buyout

November 11, 2015 Research and Development, Sales and Marketing Astellas, Ocata, Stem cells, cell therapy, ophthalmology

Astellas Pharma has agreed to buy Ocata, a firm specialising in cloning and embryonic stem cell therapies, for $379 million. …
News
roche

FDA approves Roche skin cancer combination

November 11, 2015 Research and Development, Sales and Marketing Cotellic, FDA, Genentech, Roche, Zelboraf, cobimetinib, melanoma, skin cancer, vemurafenib

The FDA has approved the skin cancer drug Cotellic for certain forms of melanoma in combination with another Roche cancer …
News
Victoza

Novo Nordisk looks to HEOR data to back Victoza

November 11, 2015 Research and Development, Sales and Marketing Byetta, HEOR, Lyxumia, NHS, Novo Nordisk, Victoza, cost-effectiveness

A Novo Nordisk-sponsored study of the cost-effectiveness of three different injectable anti-diabetes drugs has found Victoza is a cheaper option …
News

Health minister criticised for blocking Off-Patent Drugs Bill debate

November 9, 2015 Research and Development, Sales and Marketing Alistair Burt, Breast Cancer Now, MS Society, Off-Patent Drugs Bill

A Parliamentary Bill backing the wider use of off-patent drugs has been kicked into the long grass after the Government …
News
EMA HQ

EMA concludes HPV vaccines do not cause CRPS or POTS

November 9, 2015 Sales and Marketing EMA, HPV, HPV vaccine, PRAC, complex regional pain syndrome, drug safety, postural orthostatic tachycardia syndrome

The European Medicines Agency says there is no evidence from a detailed scientific review of reports linking complex regional pain …
News
UNITAID

Medicines Patent Pool to include hep C and TB drugs

November 9, 2015 Sales and Marketing Medicines Patent Pool, affordable drugs, hep C, hepatitis, hepatitis C, medicines access, tuberculosis

The Medicines Patent Pool has expanded to include a mandate to make treatments for hepatitis C and tuberculosis affordable and …
News
clinical trials

Governments and industry ‘combining to stall drug development’

November 9, 2015 Research and Development, Sales and Marketing BMJ, R&D, drug development

Both government and industry practices are responsible for the innovation deficit in the pharmaceutical sector, meaning that “the majority of …
News
Pfizer logo

Pfizer to double patient assistance allowance in the US

November 9, 2015 Sales and Marketing Drug pricing, Pfizer

Pfizer says it will double the allowable income level for its RxPathways patient assistance program in the US with immediate …
News
boehringers_current_board

Boehringer announces board changes, chairman’s retirement

November 6, 2015 Medical Communications, Sales and Marketing

Boehringer Ingelheim has announced that Professor Andreas Barner will retire as chairman of the Board of Managing Directors on 30 …
Appointment
dollar-544956_1280

Top 5 pharma companies’ Q3 results

November 6, 2015 Medical Communications, Sales and Marketing financial results, revenue, sales

The leading pharma players have been able to report largely positive financial results to their shareholders in the third quarter …
Feature
Sanofi logo

Sanofi buys in new diabetes drug

November 6, 2015 Medical Communications, Research and Development, Sales and Marketing Lexicon Pharma, SGLT2, SGLT2 inhibitors, Sanofi, sotagliflozin

Sanofi has paid an initial $300 million for collaboration and license agreement to develop sotagliflozin, one of a newer class …
News
Olivier Brandicourt

Brandicourt sets out Sanofi’s long-term vision

November 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, olivier brandicourt, pharma strategy

Sanofi has pledged to plough the money saved from its business restructure into R&D investment, to bring 18 new products …
News
Ikervis

New treatments to boost dry eye drug market – if approved

November 5, 2015 Sales and Marketing Allergan, Ikervis, Restasis, Shire, cyclosporine, dry eye disease, dry eye syndrome, lifitegrast

The global market for treatments for dry eye syndrome will double in value to an estimated $4.6 billion by 2024, …
News
OECD logo

OECD report warns of high spend and slow growth for pharma industry

November 5, 2015 Manufacturing and Production, Sales and Marketing OECD, pharmaceutical spending

The high prices that pharma companies charge for specialty medicines are straining the health budgets of wealthy nations, according to …
News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026